A Henderson, Nevada resident appeared in court on September 10, 2025, facing federal charges for allegedly smuggling and distributing misbranded prescription drugs. The indictment claims that David Ralph Webber imported capsules containing sildenafil and tadalafil—active ingredients found in FDA-approved Viagra and Cialis—from manufacturers in India. He then sold these drugs under the brand names “Kinky Kong,” “Kinky Pink,” “Stif,” “Tbone,” and “Ride” to smoke shops, convenience stores, adult novelty stores, and directly to consumers through his website.
“Americans depend on the FDA to ensure that drugs are safe and accurately labeled,” said FDA Special Agent in Charge Robert M. Iwanicki of the FDA’s Office of Criminal Investigations Los Angeles Field Office. “Today’s announcement illustrates our ongoing emphasis on holding accountable people who circumvent federal regulations and jeopardize public health.”
The federal grand jury indicted Webber on July 30, 2025. He faces one count of introducing a misbranded drug into interstate commerce, four counts of wholesale distribution of prescription drugs without a license, and seven counts of smuggling.
Court documents allege that Webber owned two Nevada companies: Passion Plus Enterprises Inc. and Whole Science Health. He was not registered with the FDA as a pharmaceutical manufacturer or licensed as a wholesaler or administrator of prescription drugs.
The indictment alleges that since at least 2018, Webber distributed hundreds of thousands of capsules containing sildenafil and tadalafil throughout Nevada and the southwestern United States. These products were sent to third-party stores as well as directly to consumers. The indictment also states that such products can have harmful effects if not administered by a licensed practitioner, especially for individuals taking heart or blood-thinning medications.
Webber is also accused of hiring a packaging company to list false ingredients on labels and claim that the drugs were “100% Natural” with no prescription required. Many consumers reportedly did not know they were ingesting medicines with active ingredients identical to those in Viagra or Cialis.
A jury trial is scheduled for November 18, 2025 before United States District Judge Jennifer A. Dorsey.
Acting United States Attorney Sigal Chattah for the District of Nevada and Special Agent in Charge Robert M. Iwanicki announced the case’s progress.
The investigation involved both the Food and Drug Administration (FDA) and United States Postal Inspection Service; Assistant United States Attorney Jean Ripley is prosecuting.
Individuals who have taken these products or suffered adverse health effects are encouraged to contact investigators via https://www.accessdata.fda.gov/scripts/email/oc/oci/contact.cfm.
An indictment is an accusation; all defendants are presumed innocent unless proven guilty.
